Bloomage BioTechnology Balance Sheet Health
Financial Health criteria checks 6/6
Bloomage BioTechnology has a total shareholder equity of CN¥7.1B and total debt of CN¥127.0M, which brings its debt-to-equity ratio to 1.8%. Its total assets and total liabilities are CN¥8.7B and CN¥1.6B respectively. Bloomage BioTechnology's EBIT is CN¥434.4M making its interest coverage ratio -32.6. It has cash and short-term investments of CN¥541.6M.
Key information
1.8%
Debt to equity ratio
CN¥126.96m
Debt
| Interest coverage ratio | -32.6x |
| Cash | CN¥541.55m |
| Equity | CN¥7.05b |
| Total liabilities | CN¥1.63b |
| Total assets | CN¥8.69b |
Recent financial health updates
Recent updates
Bloomage BioTechnology (SHSE:688363) Will Want To Turn Around Its Return Trends
Dec 13
Why Bloomage BioTechnology's (SHSE:688363) Shaky Earnings Are Just The Beginning Of Its Problems
Nov 06After Leaping 40% Bloomage BioTechnology Corporation Limited (SHSE:688363) Shares Are Not Flying Under The Radar
Sep 30Need To Know: Analysts Just Made A Substantial Cut To Their Bloomage BioTechnology Corporation Limited (SHSE:688363) Estimates
Aug 30Bloomage BioTechnology Corporation Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Aug 27Bloomage BioTechnology (SHSE:688363) Seems To Use Debt Quite Sensibly
Jun 02Weak Statutory Earnings May Not Tell The Whole Story For Bloomage BioTechnology (SHSE:688363)
May 06Getting In Cheap On Bloomage BioTechnology Corporation Limited (SHSE:688363) Might Be Difficult
May 01Financial Position Analysis
Short Term Liabilities: 688363's short term assets (CN¥2.7B) exceed its short term liabilities (CN¥1.1B).
Long Term Liabilities: 688363's short term assets (CN¥2.7B) exceed its long term liabilities (CN¥498.5M).
Debt to Equity History and Analysis
Debt Level: 688363 has more cash than its total debt.
Reducing Debt: 688363's debt to equity ratio has reduced from 1.9% to 1.8% over the past 5 years.
Debt Coverage: 688363's debt is well covered by operating cash flow (581.9%).
Interest Coverage: 688363 earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 02:01 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Bloomage BioTechnology Corporation Limited is covered by 34 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Fang Yi Cai | Changjiang Securities Co. LTD. |
| Jian Jun Zou | Chasing Securities |
| Xiyue Zhang | Chasing Securities |